These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7996427)

  • 1. Cyclic GMP but not cyclic AMP prevents renal platelet accumulation after ischemia-reperfusion in anesthetized rats.
    Chintala MS; Bernardino V; Chiu PJ
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1203-8. PubMed ID: 7996427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic GMP and cyclic AMP induced changes in control and hypertrophic cardiac myocyte function interact through cyclic GMP affected cyclic-AMP phosphodiesterases.
    Weiss HR; Gong GX; Straznicka M; Yan L; Tse J; Scholz PM
    Can J Physiol Pharmacol; 1999 Jun; 77(6):422-31. PubMed ID: 10537228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of human platelet responses by cGMP inhibited and stimulated cAMP phosphodiesterases.
    Manns JM; Brenna KJ; Colman RW; Sheth SB
    Thromb Haemost; 2002 May; 87(5):873-9. PubMed ID: 12038792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of Sildenafil on human platelet secretory function is controlled by a complex interplay between phosphodiesterases 2, 3 and 5.
    Dunkern TR; Hatzelmann A
    Cell Signal; 2005 Mar; 17(3):331-9. PubMed ID: 15567064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-activating factor modulates activity of cyclic nucleotides in fetal ovine pulmonary vascular smooth muscle.
    Ibe BO; Ameer A; Portugal AM; Renteria L; Raj JU
    J Pharmacol Exp Ther; 2007 Feb; 320(2):728-37. PubMed ID: 17085546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione.
    Gordge MP; Hothersall JS; Noronha-Dutra AA
    Br J Pharmacol; 1998 May; 124(1):141-8. PubMed ID: 9630353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin-stimulated phospholipase C activity is inhibited without visible delay by a rapid increase in the cyclic GMP levels induced by sodium nitroprusside.
    Azula FJ; Alzola ES; Conde M; Trueba M; Macarulla JM; Marino A
    Mol Pharmacol; 1996 Aug; 50(2):367-79. PubMed ID: 8700145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective mechanisms of inosine in platelet activation and cerebral ischemic damage.
    Hsiao G; Lin KH; Chang Y; Chen TL; Tzu NH; Chou DS; Sheu JR
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1998-2004. PubMed ID: 15976325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased activity of guanosine 3'-5'-cyclic monophosphate phosphodiesterase in the renal tissue of cirrhotic rats with ascites.
    Angeli P; Jiménez W; Veggian R; Fasolato S; Volpin R; MacHenzie HS; Craighero R; Libera VD; Sticca A; Arroyo V; Gatta A
    Hepatology; 2000 Feb; 31(2):304-10. PubMed ID: 10655250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Puerarin, an isoflavonoid derived from Radix puerariae, potentiates endothelium-independent relaxation via the cyclic AMP pathway in porcine coronary artery.
    Yeung DK; Leung SW; Xu YC; Vanhoutte PM; Man RY
    Eur J Pharmacol; 2006 Dec; 552(1-3):105-11. PubMed ID: 17027964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired synthesis and action of antiaggregating cyclic nucleotides in platelets from obese subjects: possible role in platelet hyperactivation in obesity.
    Anfossi G; Russo I; Massucco P; Mattiello L; Doronzo G; De Salve A; Trovati M
    Eur J Clin Invest; 2004 Jul; 34(7):482-9. PubMed ID: 15255785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelin-1 releases prostacyclin and inhibits ex vivo platelet aggregation in the anesthetized rabbit.
    Thiemermann C; Lidbury PS; Thomas GR; Vane JR
    J Cardiovasc Pharmacol; 1989; 13 Suppl 5():S138-41; discussion S142. PubMed ID: 2473289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of platelet adhesion to collagen by cGMP-elevating agents.
    Wu CC; Ko FN; Teng CM
    Biochem Biophys Res Commun; 1997 Feb; 231(2):412-6. PubMed ID: 9070290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In central obesity, weight loss restores platelet sensitivity to nitric oxide and prostacyclin.
    Russo I; Traversa M; Bonomo K; De Salve A; Mattiello L; Del Mese P; Doronzo G; Cavalot F; Trovati M; Anfossi G
    Obesity (Silver Spring); 2010 Apr; 18(4):788-97. PubMed ID: 19834474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of nitrovasodilators and inhibitors of nitric oxide synthase on ischaemic and reperfusion function of rat isolated hearts.
    du Toit EF; McCarthy J; Miyashiro J; Opie LH; Brunner F
    Br J Pharmacol; 1998 Mar; 123(6):1159-67. PubMed ID: 9559900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of endothelin-1 and cyclic nucleotides in ischemia/reperfusion-mediated microvascular leak.
    Ramirez R; Chong T; Curran B; Victorino GP
    J Trauma; 2006 Mar; 60(3):515-20; discussion 520-22. PubMed ID: 16531848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
    Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo inhibition of platelet adhesion by a cGMP-mediated mechanism in balloon catheter injured rat carotid artery.
    Vemulapalli S; Chiu PJ; Kurowski S; Brown A; Hartman BD; Leach MW
    Pharmacology; 1996 Apr; 52(4):235-42. PubMed ID: 8841086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction.
    Smits GJ; McVey M; Cox BF; Perrone MH; Clark KL
    J Pharmacol Exp Ther; 1998 Aug; 286(2):611-8. PubMed ID: 9694911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.